Delmarva

Leadership Team and Participants

Primary Contact

Maritza Izquierdo
Fresenius Health Partners
maritza.izquierdo@fmc-na.com
(512) 277-6565

Maria Radonova
Integrated Care Group,
Fresenius Health Partners
Actuary

Clinical Leadership Contact

Terry Ketchersid, MD
Integrated Care Group,
Fresenius Medical Care North America
terry.ketchersid@fmc-na.com
(512) 277-6565

Maureen Bernacki
Integrated Care Group
Finance

Facilities

BALTIMORE COUNTY DIALYSIS, LLC
BALTIMORE COUNTY LUTHERVILLE DIALYSIS, LLC
BIO-MEDICAL APPLICATIONS OF COLUMBIA HEIGHTS, INC.
BIO-MEDICAL APPLICATIONS OF DELAWARE, INC.
BIO-MEDICAL APPLICATIONS OF MARYLAND, INC.
BIO-MEDICAL APPLICATIONS OF NORTHEAST D.C., INC.
BIO-MEDICAL APPLICATIONS OF SOUTHEAST WASHINGTON, INC.
BIO-MEDICAL APPLICATIONS OF THE DISTRICT OF COLUMBIA, INC.
BIO-MEDICAL APPLICATIONS OF VIRGINIA, INC.
BIO-MEDICAL APPLICATIONS OF WEST VIRGINIA, INC.
CHARING CROSS DIALYSIS LLC
FRESENIUS ANNE ARUNDEL OUTPATIENT DIALYSIS SERVICES, LLC
FRESENIUS KIDNEY CARE CROMWELL, LLC
FRESENIUS MEDICAL CARE ESSEX DUNDALK, LLC
FRESENIUS MEDICAL CARE NORTHERN DELAWARE, LLC
FRESENIUS MEDICAL CARE NW BALTIMORE, LLC
FRESENIUS MEDICAL CARE SOUTHERN DELAWARE, LLC
FRESENIUS MEDICAL CARE SOUTHERN MARYLAND HOME, LLC
FRESENIUS MEDICAL CARE SURRATS, LLC
FRESENIUS MEDICAL CARE TOWSON, LLC
NATIONAL MEDICAL CARE, INC.
NXSTAGE GREENBELT, LLC
RAI CARE CENTERS OF DC I, LLC
RAI CARE CENTERS OF MARYLAND I, LLC
RAI CARE CENTERS OF SOUTHEAST DC, LLC
TAPPAHANNOCK DIALYSIS CENTER, INC.
WARRENTON DIALYSIS FACILITY, INC.

Participants

Bustos And Associate
Antonina Kolesnikova MD
Elwin G. Bustos MD
Fredericksburg Nephrology
Ankur Sandhu
Joan Carter
Lakshmi Turlapati
Nicole Brooks
Randy Gertner
Robert Canady
Thomas Officer
Tracy Perry
Maryland Kidney Group, PA
Aiman Shammas
Dipti Patel
Edward Bird
Irfan Shukrullah
Khalid Al-Talib
Metro Renal Associates, PLLC
Cosette Jamieson
Kevin Griffiths
Metropolitan Nephrology Associates, PC
Adam Pearlman
Eline Mul
Erica Davis
Harshal Shah
Manoj Reddy
Marc Brazie
Mitesh Shah
Samir ShabShab
Nephrology Associates, PA
Helen Chang-DeGuzman
Peter Burke
Stephanie G. Gilibert
Tarek Salkini, M.D.
Tarek Salkini, M.D.
Washington Nephrology Associates, LLP
Adnan Hashmi
Ali Ghorbani
Anup Manoharan
BALA SUBRAMANIAN
Dhaval Aghera
Fahim Malik
Gail L Seiken
Harpreet S Bhutani
Hassan Shahin
Jagdeep Obhrai
Jeremy Marcus
Joselito Cabacar
Kryt Chattrabhuti
Mayurkumar Gohel
Mohammad Khan
Padmaja Kolachana
Saeed J Kronfli
Sandesh Joshi
Tariq Rehman
Youssef Hokayem
Zahid Iqbal
Ziad Al Khouri

Kidney Care Choices Model Implementation Period Notice of Waiver

The Centers for Medicare and Medicaid Services and the U.S. Department of Health and Human Services’ Office of Inspector General have provided certain waivers of federal fraud and abuse laws in connection with participation during the Implementation Period in the Comprehensive Kidney Care Contracting (“CKCC”) Option of the Kidney Carse Choices (“KCC”) Model (“KCC Implementation Period Waivers”). In accordance with such Waivers, the KCE provides notice that the Implementation Period KCE Activities arrangement described below is being provided under the protection of the KCC Implementation Period Waivers.

Implementation Period KCE Activities: The Board of Managers of Delmarva Kidney Care Entity, LLC (the “CE”) has duly authorized the following arrangement and has made a bona fide determination that this arrangement is reasonably related to the performance of KCE Activities during the Implementation Period because the arrangement is in preparation for and will promote the future accountability for the quality, cost, and overall care for KCE Beneficiaries. As of October 19, 2021, the KCE has engaged BIO-MEDICAL APPLICATIONS OF WEST VIRGINIA, INC., a KCE Preferred Provider, to provide certain services and items in preparation for the start of the Performance Year. Such services and items include care coordination and management services, education related to performance under a risked-based financial arrangement, and information technology to improve care processes and to prepare for the assumption of financial risk under the KCC Model.

The KCE will publicly disclose on this website additional arrangements that qualify for the KCC Implementation Period Waivers as they are authorized by its governing board, in compliance with public disclosure requirements.

Company

Fresenius Medical Care Holdings, Inc.
Fresenius Seamless Care
PO Box 162970
Austin, TX 78716-2970

Governing Body

Nephrology Associates, William J. Dahms
Fresenius Health Partners, Maritza Izquierdo
Independent Consumer Advocate, Tracy Woodson